Rightslink® by Copyright Clearance Center

CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies

Author:

Olivia Perez de Acha,Lauren Reiman,David S. Jayabalan,Zachary J. Walker,Grace Bosma,Alana L. Keller,Sarah E. Parzych,Diana Abbott,Beau M. Idler,Drew Ribadeneyra,Ruben Niesvizky,Peter A. Forsberg,Tomer M. Mark,Daniel W. Sherbenou

Publication:

Blood Advances

Publisher:

Elsevier

Date:

14 November 2023

© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Content Excluded

This content has been excluded from the RightsLink's service. Please contact Elsevier directly with your request.